Takeda Pharmaceuticals U.S.A. v. Mylan Pharmaceuticals Inc.
MYLAN PHARMACEUTICALS INC. |
TAKEDA PHARMACEUTICALS U.S.A., INC. |
20-1417 |
January 31, 2020 |
U.S. Court of Appeals, Federal Circuit |
Other |
Docket Report
This docket was last retrieved on February 19, 2020. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 15 Note to file: The following cases are associated:20-1407 (Lead) with 20-1417 (Member Case). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [672567] [20-1407, 20-1417] [TAM] [Entered: 02/19/2020 04:33 PM] |
Filing 14 ORDER consolidating the appeals. The revised official caption is reflected above. One set of briefs should be filed for the two appeals. Takeda's opening brief remains due no later than February 19, 2020. Service as of this date by the Clerk of Court. [672520] [20-1407, 20-1417] [LMS] [Entered: 02/19/2020 03:33 PM] |
Filing 13 Entry of appearance for Shyamkrishna Palaiyanur as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 02/13/2020 by email. [671183] [20-1417] [Shyamkrishna Palaiyanur] [Entered: 02/13/2020 04:53 PM] |
Filing 12 Entry of appearance for Sheryl Shapiro Bassin as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 02/13/2020 by email. [671182] [20-1417] [Sheryl Shapiro Bassin] [Entered: 02/13/2020 04:51 PM] |
Filing 11 Entry of appearance for Jessica L. Margolis as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 02/13/2020 by email. [671181] [20-1417] [Jessica Margolis] [Entered: 02/13/2020 04:49 PM] |
Filing 10 Docketing Statement for the Appellee Mylan Pharmaceuticals Inc.. Service: 02/13/2020 by email. [671179] [20-1417] [Michael Sommer] [Entered: 02/13/2020 04:47 PM] |
Filing 9 Certificate of Interest for Appellee Mylan Pharmaceuticals Inc.. Service: 02/13/2020 by email. [671178] [20-1417] [Michael Sommer] [Entered: 02/13/2020 04:46 PM] |
Filing 8 Entry of appearance for Michael S. Sommer as of counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 02/13/2020 by email. [671177] [20-1417] [Michael Sommer] [Entered: 02/13/2020 04:45 PM] |
Filing 7 Docketing Statement for the Appellant Takeda Pharmaceuticals U.S.A., Inc.. Service: 02/12/2020 by email. [670844] [20-1417] [Edgar Haug] [Entered: 02/12/2020 03:43 PM] |
Filing 6 Certificate of Interest for Appellant Takeda Pharmaceuticals U.S.A., Inc.. Service: 02/12/2020 by email. [670842] [20-1417] [Edgar Haug] [Entered: 02/12/2020 03:42 PM] |
Filing 5 Entry of appearance for Camille Y. Turner as of counsel for Appellant Takeda Pharmaceuticals U.S.A., Inc.. Service: 02/12/2020 by email. [670840] [20-1417] [Jonathan Herstoff] [Entered: 02/12/2020 03:40 PM] |
Filing 4 Entry of appearance for Jonathan A. Herstoff as of counsel for Appellant Takeda Pharmaceuticals U.S.A., Inc.. Service: 02/12/2020 by email. [670838] [20-1417] [Jonathan Herstoff] [Entered: 02/12/2020 03:38 PM] |
Filing 3 Entry of appearance for Porter F. Fleming as of counsel for Appellant Takeda Pharmaceuticals U.S.A., Inc.. Service: 02/12/2020 by email. [670836] [20-1417] [Porter Fleming] [Entered: 02/12/2020 03:37 PM] |
Filing 2 Entry of appearance for Edgar H. Haug as principal counsel for Appellant Takeda Pharmaceuticals U.S.A., Inc.. Service: 02/12/2020 by email. [670834] [20-1417] [Edgar Haug] [Entered: 02/12/2020 03:34 PM] |
Filing 1 Appeal docketed. Received: 01/28/2020. [667547] Entry of Appearance due 02/14/2020. Certificate of Interest is due on 02/14/2020. Docketing Statement due 02/14/2020. Appellant's brief is due 03/31/2020. [TAM] [Entered: 01/31/2020 09:43 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.